Ruth Mckernan's Insider Trades & SAST Disclosures

Ruth Mckernan's most recent trade in Cerevel Therapeutics Holdings Inc was a trade of 10,461 Common Stock done . Disclosure was reported to the exchange on June 5, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cerevel Therapeutics Holdi...
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 13,743 - - Common Stock
Cerevel Therapeutics Holdi...
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Cerevel Therapeutics Holdi...
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 3,282 - - Common Stock
Cerevel Therapeutics Holdi...
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Cerevel Therapeutics Holdi...
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 80,945 80,945 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades